Patients Deserve Better: Harnessing Innovation and Empathy to Reshape Drug Development for Rare Diseases
In this talk, Michelle C. Werner, CEO of Alltrna and CEO-Partner at Flagship Pioneering, will explore the interplay between scientific innovation, patient advocacy, and bold leadership in biotech. Sharing insights from her journey as a pharma executive, biotech CEO, and parent of a child with Duchenne muscular dystrophy, Michelle will underscore the importance of leading with empathy, embracing risk, and driving innovation with urgency. Her talk will showcase how advancements in tRNA medicines and other novel therapeutic platforms have the potential to revolutionize drug development for underserved populations, including rare and ultra-rare diseases, reshaping the future of medicine.
Don’t just keep up... Lead the way in clinical pharmacology and translational science! Join the ASCPT Annual Meeting for industry-leading insights and unmatched networking. Register Today!
.jpg "Sandra A.G Visser, PhD (she/her/hers) photo")